Mitochondrial Targets for Stroke
Author(s) -
Peter S. Vosler,
Steven H. Graham,
Lawrence R. Wechsler,
Jun Chen
Publication year - 2009
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.108.543769
Subject(s) - autophagy , neuroprotection , medicine , mitochondrial biogenesis , stroke (engine) , neuroscience , mitochondrion , signal transduction , programmed cell death , bioinformatics , cause of death , microbiology and biotechnology , apoptosis , pharmacology , pathology , biology , disease , genetics , mechanical engineering , engineering
Stroke is a major cause of death and disability, and it is imperative to develop therapeutics to mitigate stroke-related injury. Despite many promising prospects, attempts at translating neuroprotective agents that show success in animal models of stroke have resulted in very limited clinical success.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom